I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
0.9450
+0.0650 (7.39%)
At close: May 12, 2025, 4:00 PM
0.8978
-0.0472 (-4.99%)
After-hours: May 12, 2025, 4:15 PM EDT
I-Mab Market Cap
I-Mab has a market cap or net worth of $77.02 million as of May 12, 2025. Its market cap has decreased by -47.27% in one year.
Market Cap
77.02M
Enterprise Value
-92.50M
1-Year Change
-47.27%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has decreased from $138.05M to $77.02M, a decrease of -44.21%. That is a compound annual growth rate of -10.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 71.72M | 3.61% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |